Home

Schizophrenia

Read time: 3 min

Congress highlights

Finding the sweet spot for pharmacotherapy in schizophrenia

Over recent years, the goals in the management of patients with schizophrenia have evolved from...

Read time: 4 min

Congress highlights

What's new? Research highlights in psychotic disorders

At ECNP 2017, we were kept up-to-date with exciting research in psychotic disorders from the past...

Read time: 3 min

Congress highlights

Developments in disease understanding aid treatment innovation

Instead of assigning patients with psychosis to diagnostic categories, we might concentrate on the...

Read time: 3 min

Congress highlights

Aerobic exercise improves mental well being

Get on your running shoes if you want good mental health in later life – it’s never too...

Read time: 4 min

Congress highlights

New biological insights emerge via genetic studies in schizophrenia

Schizophrenia is a clinically-defined syndrome and not a single biological entity. Even so, the...

Read time: 4 min

Congress highlights

Treatment resistant schizophrenia – less urban myth than rural reality

Treatment resistant schizophrenia (TRS) is an on-going challenge in psychiatry. Too often available...

Read time: 3 min

An e-health tool to aid in schizophrenia treatment selection

With the increasing number of antipsychotic drugs available, is it possible to match an agent to a...

Read time: 2 min

Satellite symposium

Priorities and preferences of people with schizophrenia: need for new focus

Priorities are what people value, and preferences show how they make trade-offs between one outcome...

Depression, Schizophrenia

Read time: 5 min

Congress highlights

Breaking boundaries

While the causes of psychiatric disorders are still not well understood, we do know that many...

Read time: 4 min

Congress highlights

Keeping a healthy brain

Preventing the long-term consequences of schizophrenia, and particularly of multiple relapses, is...

Read time: 4 min

Satellite symposium

Preventing schizophrenia relapse key to optimizing outcome

Sustained remission and good functional outcome depend on the interaction between factors we cannot...

Read time: 3 min

Congress highlights

Positive action on negative symptoms

Negative symptoms are experienced by more than 50% of patients with schizophrenia. They are often a...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country